| Product Code: ETC7629303 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Enteric Disease Testing-Treatment Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Enteric Disease Testing-Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Enteric Disease Testing-Treatment Market - Industry Life Cycle |
3.4 Ireland Enteric Disease Testing-Treatment Market - Porter's Five Forces |
3.5 Ireland Enteric Disease Testing-Treatment Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 Ireland Enteric Disease Testing-Treatment Market Revenues & Volume Share, By Therapeutics, 2021 & 2031F |
3.7 Ireland Enteric Disease Testing-Treatment Market Revenues & Volume Share, By Testing Technology, 2021 & 2031F |
3.8 Ireland Enteric Disease Testing-Treatment Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 Ireland Enteric Disease Testing-Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of early detection and treatment of enteric diseases in Ireland |
4.2.2 Rising prevalence of enteric diseases in the region |
4.2.3 Technological advancements in enteric disease testing and treatment methods |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of enteric disease testing and treatment products |
4.3.2 Limited healthcare infrastructure and resources in certain regions of Ireland |
4.3.3 High cost associated with advanced enteric disease testing and treatment options |
5 Ireland Enteric Disease Testing-Treatment Market Trends |
6 Ireland Enteric Disease Testing-Treatment Market, By Types |
6.1 Ireland Enteric Disease Testing-Treatment Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Enteric Disease Testing-Treatment Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 Ireland Enteric Disease Testing-Treatment Market Revenues & Volume, By Bacterial Enteric Diseases, 2021- 2031F |
6.1.4 Ireland Enteric Disease Testing-Treatment Market Revenues & Volume, By Viral Enteric Diseases, 2021- 2031F |
6.1.5 Ireland Enteric Disease Testing-Treatment Market Revenues & Volume, By Parasitic Enteric Diseases, 2021- 2031F |
6.2 Ireland Enteric Disease Testing-Treatment Market, By Therapeutics |
6.2.1 Overview and Analysis |
6.2.2 Ireland Enteric Disease Testing-Treatment Market Revenues & Volume, By Campylobacter, 2021- 2031F |
6.2.3 Ireland Enteric Disease Testing-Treatment Market Revenues & Volume, By Cryptosporidium, 2021- 2031F |
6.2.4 Ireland Enteric Disease Testing-Treatment Market Revenues & Volume, By E-Coli, 2021- 2031F |
6.2.5 Ireland Enteric Disease Testing-Treatment Market Revenues & Volume, By Enteroviruses, 2021- 2031F |
6.2.6 Ireland Enteric Disease Testing-Treatment Market Revenues & Volume, By RhinoViruses, 2021- 2031F |
6.2.7 Ireland Enteric Disease Testing-Treatment Market Revenues & Volume, By RotaVirus, 2021- 2031F |
6.2.8 Ireland Enteric Disease Testing-Treatment Market Revenues & Volume, By Shigellosis, 2021- 2031F |
6.2.9 Ireland Enteric Disease Testing-Treatment Market Revenues & Volume, By Shigellosis, 2021- 2031F |
6.3 Ireland Enteric Disease Testing-Treatment Market, By Testing Technology |
6.3.1 Overview and Analysis |
6.3.2 Ireland Enteric Disease Testing-Treatment Market Revenues & Volume, By Molecular Diagnostics, 2021- 2031F |
6.3.3 Ireland Enteric Disease Testing-Treatment Market Revenues & Volume, By Monoclonal Antibodies, 2021- 2031F |
6.3.4 Ireland Enteric Disease Testing-Treatment Market Revenues & Volume, By Immunoassays, 2021- 2031F |
6.3.5 Ireland Enteric Disease Testing-Treatment Market Revenues & Volume, By Differential Light Scanning, 2021- 2031F |
6.3.6 Ireland Enteric Disease Testing-Treatment Market Revenues & Volume, By Information Technology, 2021- 2031F |
6.3.7 Ireland Enteric Disease Testing-Treatment Market Revenues & Volume, By AI, 2021- 2031F |
6.3.8 Ireland Enteric Disease Testing-Treatment Market Revenues & Volume, By Flow Cytometry, 2021- 2031F |
6.3.9 Ireland Enteric Disease Testing-Treatment Market Revenues & Volume, By Flow Cytometry, 2021- 2031F |
6.3.10 Ireland Enteric Disease Testing-Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Ireland Enteric Disease Testing-Treatment Market, By End users |
6.4.1 Overview and Analysis |
6.4.2 Ireland Enteric Disease Testing-Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Ireland Enteric Disease Testing-Treatment Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.4.4 Ireland Enteric Disease Testing-Treatment Market Revenues & Volume, By Physician Offices, 2021- 2031F |
7 Ireland Enteric Disease Testing-Treatment Market Import-Export Trade Statistics |
7.1 Ireland Enteric Disease Testing-Treatment Market Export to Major Countries |
7.2 Ireland Enteric Disease Testing-Treatment Market Imports from Major Countries |
8 Ireland Enteric Disease Testing-Treatment Market Key Performance Indicators |
8.1 Percentage increase in the adoption of enteric disease testing and treatment services in Ireland |
8.2 Average turnaround time for enteric disease test results |
8.3 Percentage of healthcare professionals trained in the latest enteric disease testing and treatment protocols |
9 Ireland Enteric Disease Testing-Treatment Market - Opportunity Assessment |
9.1 Ireland Enteric Disease Testing-Treatment Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 Ireland Enteric Disease Testing-Treatment Market Opportunity Assessment, By Therapeutics, 2021 & 2031F |
9.3 Ireland Enteric Disease Testing-Treatment Market Opportunity Assessment, By Testing Technology, 2021 & 2031F |
9.4 Ireland Enteric Disease Testing-Treatment Market Opportunity Assessment, By End users, 2021 & 2031F |
10 Ireland Enteric Disease Testing-Treatment Market - Competitive Landscape |
10.1 Ireland Enteric Disease Testing-Treatment Market Revenue Share, By Companies, 2024 |
10.2 Ireland Enteric Disease Testing-Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here